Su1488: WITHIN 6 MONTHS FROM COVID-19 BNT162B2 VACCINE PATIENTS WITH INFLAMMATORY BOWEL DISEASES TREATED WITH ANTI-TNFα HAVE SIGNIFICANTLY LOWER SEROLOGIC RESPONSES

Detalles Bibliográficos
Autores principales: Rabinowitz, Keren M., Navon, Michal, Edelman-Klapper, Hadar, Zittan, Eran, Shitrit, Ariella Bar-Gil, Goren, Idan, Avni-Biron, Irit, Ollech, Jacob, Lichtenstein, Lev, Banai, Hagar, Yanai, Henit A., Snir, Yifat, H.Pauker, Maor, Friedenberg, Adi, Levy-Barda, Adva, Segal, Arie, Broitman, Yelena, Maoz, Eran, Ovadia, Baruch, Golan, Maya Aharoni, Shachar, Eyal, Ben-Horin, Shomron, Perets, Tsachi-Tsadok, Zvi, Haim Ben, Eliakim, Rami, Barkan, Revital, Goren, Sophy, Krugliak, Noy, Werbner, Michal, Alter, Joel, Dessau, Moshe, Tanamy, Meital Gal, Cohen, Daniel, Freund, Natalia T., Dotan, Iris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AGA Institute. Published by Elsevier Inc. 2022
Materias:
AGA Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212456/
http://dx.doi.org/10.1016/S0016-5085(22)61410-0

Ejemplares similares

Ejemplares similares